Who is sponsoring NCT03779373?

NCT03779373 is sponsored by Erasme University Hospital.

What drugs are being tested in NCT03779373?

Interventions in NCT03779373: Use of a decision support system on the EV1000 monitor (AFM mode).

What condition does NCT03779373 study?

NCT03779373 studies Goal Directed Fluid Therapy.

Is NCT03779373 still recruiting?

NCT03779373 is currently withdrawn. Last updated 14 May 2019.

Last reviewed 2019-05-14 · How we verify

NCT03779373: AFM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assisted Fluid Management in Patients Undergoing Major Abdominal and Orthopedic Surgery

Withdrawn NA Last updated 14 May 2019

What this trial tests

NA trial testing Use of a decision support system on the EV1000 monitor (AFM mode) in Goal Directed Fluid Therapy. Withdrawn.

Timeline

1 April 2019

Primary endpoint
1 July 2020

30 July 2020

Quick facts

Lead sponsor	Erasme University Hospital
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Start date	1 April 2019
Primary completion	1 July 2020
Estimated completion	30 July 2020
Sites	1 location across France

Drugs / interventions tested

Use of a decision support system on the EV1000 monitor (AFM mode)

Conditions studied

Goal Directed Fluid Therapy — all drugs for Goal Directed Fluid Therapy →

Sponsor

Erasme University Hospital

Who can join

Adults 18 to 99, any sex, with Goal Directed Fluid Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will compare a group of patients managed with a manual GDFT protocol (using the EV1000 monitoring device; Edwards Lifesciences, Irvine, USA) to a group of patients managed using a decision support system for GDFT guidance (implemented on the same EV1000 monitoring) in patients undergoing major abdominal and orthopedic surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Erasme University Hospital trials

Trials by the same sponsor.

NCT07532733 — Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure · NA · not yet recruiting
NCT07532681 — Effect of Early Versus Late Surgical Intercostal Block on Postoperative Pain Relief Following Video-Assisted Thoracic Su · NA · not yet recruiting
NCT07457879 — Impact of the Reimbursement of Fibrinogen in Cardiac Surgery · not yet recruiting
NCT07184593 — Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients · not yet recruiting
NCT07369232 — Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03779373 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erasme University Hospital
Last refreshed: 14 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03779373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing